Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 100+ key pharma and biotech companies are working on 100+ pipeline drugs in the Hypertension therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development expected to […]
